Kevin Bihan

8PUBLICATIONS
48CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 07, 2025
Respiratory Disorders Associated with Antibody-Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases.

Victor Mirleau, Alex Hlavaty, Etienne-Marie Jutant

|Jun 16, 2025
Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors.

Léonard Laurent, Baptiste Abbar, Kevin Bihan

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Dec 23, 2022
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients.

Noël Zahr, Saik Urien, Benoit Llopis

|Aug 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study.

Alberto Picca, Cristina Birzu, Giulia Berzero

Pageof 2